Nuveen Asset Management, LLC Alector, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 260,106 shares of ALEC stock, worth $465,589. This represents 0.0% of its overall portfolio holdings.

Number of Shares

260,106

Previous 269,100 3.34%

Holding current value

$465,589

Previous $1.22 Million 0.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $39,033 - $59,180	-8,994 Reduced 3.34%	260,106 $1.21 Million
Q2 2024 Aug 09, 2024	SELL	$4.19 - $6.23 $296,584 - $440,984	-70,784 Reduced 20.83%	269,100 $1.22 Million
Q1 2024 May 13, 2024	SELL	$5.69 - $8.08 $528,071 - $749,880	-92,807 Reduced 21.45%	339,884 $2.05 Million
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $4,316 - $9,606	1,145 Added 0.27%	432,691 $3.45 Million
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $7,836 - $13,216	1,507 Added 0.35%	431,546 $2.8 Million
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $12,118 - $16,399	2,068 Added 0.48%	430,039 $2.58 Million
Q1 2023 May 15, 2023	SELL	$5.85 - $9.84 $132,818 - $223,407	-22,704 Reduced 5.04%	427,971 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $790,002 - $1.1 Million	114,826 Added 34.19%	450,675 $4.16 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $480,818 - $774,945	58,708 Added 21.18%	335,849 $3.18 Million
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $58,468 - $108,836	7,643 Added 2.84%	277,141 $2.82 Million
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $1.52 Million - $2.43 Million	-117,093 Reduced 30.29%	269,498 $3.95 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $725,238 - $957,239	37,480 Added 10.74%	386,591 $7.98 Million
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $2.53 Million - $4.62 Million	116,871 Added 50.32%	349,111 $7.97 Million
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $365,490 - $530,078	23,580 Added 11.3%	232,240 $4.84 Million
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $60,116 - $90,053	-4,051 Reduced 1.9%	208,660 $4.2 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $157,713 - $280,192	-16,778 Reduced 7.31%	212,711 $3.22 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $331,388 - $784,767	31,441 Added 15.88%	229,489 $2.42 Million
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $1.22 Million - $1.84 Million	55,709 Added 39.14%	198,048 $4.84 Million
Q1 2020 May 14, 2020	BUY	$16.25 - $35.28 $436,735 - $948,185	26,876 Added 23.28%	142,339 $3.43 Million
Q4 2019 Feb 14, 2020	SELL	$14.17 - $20.3 $51,777 - $74,176	-3,654 Reduced 3.07%	115,463 $1.99 Million
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $1.34 Million - $2.07 Million	93,252 Added 360.53%	119,117 $1.72 Million
Q2 2019 Aug 15, 2019	BUY	$16.26 - $26.42 $420,564 - $683,353	25,865 New	25,865 $492,000

Others Institutions Holding ALEC

# of Institutions

170

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $148M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Alector, Inc. Transaction History